Clinical Trial Update: An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer [NA]

View source ↗

Summary

An exploratory neoadjuvant study is evaluating a three-drug combination of dalpiciclib, letrozole, and anlotinib for Stage II-III postmenopausal HR+/HER2- early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Dalpiciclib (dalpiciclib)
• Letrozole (letrozole)

Snippet

Sponsor: Liu Shu | Conditions: Breast Cancer | NA | Status: NOT_YET_RECRUITING